You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Baxter
Merck
Mallinckrodt
Moodys

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209105


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 209105 describes ATOVAQUONE, which is a drug marketed by Abhai Llc, Amneal Pharms, Apotex, Glenmark Pharms, Hetero Labs Ltd Iii, Lupin Ltd, Paddock Llc, Glenmark Generics, and Mylan, and is included in nine NDAs. It is available from eight suppliers. Additional details are available on the ATOVAQUONE profile page.

The generic ingredient in ATOVAQUONE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Summary for 209105
Tradename:ATOVAQUONE
Applicant:Lupin Ltd
Ingredient:atovaquone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 209105
Medical Subject Heading (MeSH) Categories for 209105
Suppliers and Packaging for NDA: 209105
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATOVAQUONE atovaquone SUSPENSION;ORAL 209105 ANDA Lupin Pharmaceuticals, Inc. 68180-282 68180-282-01 1 BOTTLE in 1 CARTON (68180-282-01) > 210 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength750MG/5ML
Approval Date:Sep 11, 2018TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
McKinsey
Boehringer Ingelheim
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.